HOME (EN)

Welcome to the website of the BIOMEDICAL RESEARCH IN ENDSTAGE AND OBSTRUCTIVE LUNG DISEASE HANNOVER (BREATH) research network.

BREATH uniquely unites internationally recognized expertise in translational respiratory medicine and is one of the five sites of the German Center for Lung Research (DZL).

Funded by

NEWS

JANUARY 2018: DZL-funded clinical study shows direct influence of the drug combination Lumacaftor/Ivacaftor on CFTR function for the first time

FEBRUARY 2018: BREATH involved in successful international study for new treatment approaches for CF

Financial aid for the development of the biohybrid lung

Pathway to join DZL:

current job offers....

more News

Keine Artikel in dieser Ansicht.

Impressum | Datenschutz

MEET AND GREET

JANUARY 2018: DZL-funded clinical study shows direct influence of the drug combination Lumacaftor/Ivacaftor on CFTR function for the first time

FEBRUARY 2018: BREATH involved in successful international study for new treatment approaches for CF

Financial aid for the development of the biohybrid lung

Pathway to join DZL: